UCB Launches Nile AI as a Digital Health Company to Transform the Course of Epilepsy

 UCB Launches Nile AI as a Digital Health Company to Transform the Course of Epilepsy

UCB, Launches, Nile AI, Digital Health Company, Epilepsy

Shots:

  • UCB invested $29.3M in Nile and as majority shareholder, will be the Board of Directors of Nile with future opportunities to acquire insights and data from Nile’s platform
  • Nile is developing a digital epilepsy care management platform and bringing together data to make the epilepsy journey predictable. The platform consists of patient app and HCP portal & is anticipated to be commercially available in 2021
  • Nile’s platform will serve as a digital extension of the HCPs with an aim of shortening the path to optimal treatment

Click here ­to­ read full press release/ article | Ref: UCB | Image: Pharmaphorum

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post